It has been demonstrated that A1AT prevents glutamate toxicity in neurogenerative models like Alzheimer’s disease, where cytotoxicity triggers neurodegeneration [151,152]. Here, SERPINA1 is linked to early-onset autosomal dominant Alzheimer disease.